78 Results for "

ALK2

" in MedChemExpress (MCE) Product Catalog:
Products (78)

78 Results for "ALK2" in MCE Product Catalog:

Cat. No.: HY-173149
CAS No.: 3052084-77-9
CDD-2789 is a potent and selective ALK2 inhibitor with an IC50 0.54 μM and a Kd of 2.1 nM, respectively. CDD-2789 exhibits >120-fold selectivity over ALK3/5/6. CDD-2789 reduces activin A- and BMP2-induced SMAD1/5 phosphorylation in fibroblasts. CDD-2789 can be used for ALK2-related cancer research .
loading...
    loading...
Cat. No.: HY-149591
CAS No.: 2600795-07-9
M4K2009 is an orally active, blood-brain barrier permeable type I ALK2 inhibitor, with an IC50 value of 8-13 nM against human ALK2. M4K2009 exhibits moderate off-target inhibitory activity against hERG potassium channels (Potassium Channel), with an IC50 of 8 μM against the human channel. M4K2009 can be used in studies related to diffuse intrinsic pontine glioma [2] .
loading...
    loading...
Cat. No.: HY-12273R
CAS No.: 1206711-16-1
DMH-1 (Standard) is the analytical standard of DMH-1. DMH-1 is a potent and selective BMP inhibitor with IC50s of 27/107.9/<5/47.6 nM for ALK1/ALK2/ALK3/ALK6, respectively.
loading...
    loading...
Cat. No.: HY-151289
CAS No.: 2785430-90-0
Purity:  98.21%
Research Areas:  

Cancer

ALK5-IN-34 is an selective orally active activin receptor-like kinase (ALK) inhibitor. ALK5-IN-34 can inhibit the activity of ALK5-IN-34 with an IC50 value of ≤10 nM. ALK5-IN-34 also has inhibitory of tumor growth and can be used for the research of proliferative diseases, such as cancer .
loading...
    loading...
Cat. No.: HY-12273G
CAS No.: 1206711-16-1
DMH-1 (GMP) is GMP grade DMH-1 (HY-12273). DMH-1 (GMP) is a selective BMP inhibitor. DMH-1 (GMP) upregulates the expression of SOX1. DMH-1 (GMP) increases cardiomyocyte progenitor cells and promotes the differentiation of mouse embryonic stem cells into cardiomyocytes. DMH-1 (GMP) induces the differentiation of hiPSC-derived neural progenitor cells into β3-tubulin-positive neurons [2].
loading...
    loading...
Cat. No.: HY-155939
CAS No.: 2863635-04-3
Purity:  98.30%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2163 dihydrochloride is a potent, selective, blood-brain barrier (BBB) permeable activin receptor-like kinase-2 (ALK2) inhibitor, with an IC50 of 19 nM. M4K2163 dihydrochloride can be used in the research of diffuse intrinsic pontine glioma (DIPG) [2].
loading...
    loading...
Cat. No.: HY-176941
CAS No.: 2600795-23-9
Target:  

TGF-β Receptor

Research Areas:  

Cancer

ALK2-IN-6 (Compound 14a) is a selective ALK2 inhibitor, with an IC50 of 9 nM. ALK2-IN-6 can be used in the research of diffuse intrinsic pontine glioma .
loading...
    loading...
Cat. No.: HY-109179A
CAS No.: 2409543-84-4
Purity:  99.43%
Synonyms: TP-0184 hydrochloride
Itacnosertib hydrochloride (TP-0184 hydrochloride) is the inhibitor for FLT3, ACVR1 (ALK2, IC50=8 nM) and JAK2 (IC50=8540 nM). Itacnosertib hydrochloride exhibits anti-leukemic activity [2].
loading...
    loading...
Cat. No.: HY-P990022
CAS No.: 2566473-71-8
Synonyms: DS-6016A

Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

Prafnosbart (DS-6016A) is an IgG1-kappa, anti-ACVR1 (activin A receptor type 1, ACVRLK2, ALK2, ACVR1A, SKR1) humanized monoclonal antibody. Prafnosbart can be used for bone metabolism disorders research .
loading...
    loading...
Cat. No.: HY-19628A
CAS No.: 2387510-88-3
Research Areas:  

Inflammation/Immunology

OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM. OD36 hydrochloride is a macrocyclic inhibitor with potent binding to the ALK2 kinase ATP pocket. OD36 hydrochloride shows ALK2-directed activity with KDs of 37 nM [2].
loading...
    loading...
Cat. No.: HY-146694
CAS No.: 2245820-70-4
RIPK2-IN-1 (compound 18f) is a potent RIPK2 inhibitor with an IC50 of 51 nM. RIPK2-IN-1 inhibits ALK2 with an IC50 of 5 nM. RIPK2-IN-1 has an IC50 of 390 nM on RIPK2/NOD2 in cell assay .
loading...
    loading...
Cat. No.: HY-151275
CAS No.: 2785430-84-2
Research Areas:  

Cancer

ALK5-IN-28 (Compound Ex-05) is a selective ALK-5 inhibitor (IC50 ≤ 10 nM) that inhibits TGF-β-induced SMAD signaling. ALK5-IN-28 has the potential to inhibit tumor growth in vivo. ALK5-IN-28 can be used in the research of proliferative diseases such as cancer [2].
loading...
    loading...
Cat. No.: HY-P11354
THR-123 is an orally active ALK3 peptide agonist. THR-123 has a relatively weak binding to ALK2, but does not bind to ALK6. THR-123 suppresses inflammation, apoptosis and the epithelial-to-mesenchymal transition program and reverses established fibrosis in five mouse models of acute and chronic renal injury. THR-123 can be used for the study of kidney fibrosis .
loading...
    loading...
Cat. No.: HY-153246
CAS No.: 2414149-20-3
Research Areas:  

Cancer

ALK2-IN-5, pyrazolopyrimidine compound, is an ALK2 inhibitor. ALK2-IN-5 can inhibit ALK2 activity and FGFR activity. ALK2-IN-5 can be used for the research of disorders associated with ALK2 activity and/or FGFR activity, such as cancer .
loading...
    loading...
Cat. No.: HY-156470
CAS No.: 3009081-73-3
Multi-kinase-IN-6 (compound 10e) is a multikinase inhibitor that shows good enzyme inhibitory activity against TrkA, ALK2, c-KIT, EGFR, PIM1, CK2α, CHK1, and CDK2. Multi-kinase-IN-6 reveals antiproliferative activity against MCF7, HCT116 and EKVX with IC50 values of 3.36 μM, 1.40 μM and 3.49 μM, respectively. Multi-kinase-IN-6 shows cell cycle arrest at the G1/S phase and G1 phase in MCF7 and HCT116 cells with good apoptotic effect .
loading...
    loading...
Cat. No.: HY-136773A
CAS No.: 2416307-25-8
Purity:  98.93%
Synonyms: ALK2-IN-4 succinate
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease

KER047 succinate (ALK2-IN-4 succinate) is a potent activin receptor-like kinase-2 (ALK2) inhibitor. KER047 succinate can be used for the research of metabolic disease, such as fibrodysplasia ossificans progressiva (FOP).
loading...
    loading...
Cat. No.: HY-P11354A
THR-123 TFA is an orally active ALK3 peptide agonist. THR-123 TFA has a relatively weak binding to ALK2, but does not bind to ALK6. THR-123 TFA suppresses inflammation, Apoptosis and the epithelial-to-mesenchymal transition program and reverses established fibrosis in five mouse models of acute and chronic renal injury. THR-123 TFA can be used for the study of kidney fibrosis .
loading...
    loading...
Cat. No.: HY-12071BR
CAS No.: 1435934-00-1
Synonyms: DM-3189 dihydrochloride (Standard)
Research Areas:  

Cancer

LDN193189 (DM-3189) dihydrochloride (Standard) is the analytical standard of LDN193189 dihydrochloride (HY-12071B). This product is intended for research and analytical applications. LDN193189 (DM-3189) dihydrochloride is a potent selective BMP type I receptor (BMP I) inhibitor. LDN193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 values of 5 nM and 30 nM, respectively. LDN193189 can be used for the research of bone morphogenetic protein signalling, such as fibrodysplasia ossificans progressiva [2] .
loading...
    loading...
Cat. No.: HY-167864
CAS No.: 3034840-18-8
Target:  

TGF-β Receptor

Research Areas:  

Cancer

M4K2308 is a selective ether-linked inhibitor of ALK2 with an IC50 of 2 nM. M4K2308 exhibits exceptional selectivity for ALK2 over ALK5 (IC50 of 224 nM). M4K2308 has the potential for the study of diffuse intrinsic pontine glioma (DIPG) research .
loading...
    loading...
Cat. No.: HY-112414
CAS No.: 216661-57-3
Target:  

TGF-β Receptor

Research Areas:  

Metabolic Disease Cancer

ALK2-IN-7 is a ALK2 (ACVR1) inhibitor. ALK2-IN-7 is applicable to studies related to BMP/ALK2 signaling, anemia associated with iron homeostasis imbalance, and multiple osteochondromas .
loading...
    loading...